Author:
Baka S.,Manegold C.,Buchholz E.,Schott-von-Römer K.,Lorigan P.,Nagel S.,Blackhall F.,Aschroft L.,Thatcher N.
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference24 articles.
1. Phase I dose-finding study of gemcitabine and ifosfamide in advanced NSCLC;Eberhard;Proc Amer Soc Clin Oncol,1995
2. Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancer;Gatzemeier;Semin Oncol,1998
3. Cisplatin–carboplatin–gemcitabine or ifosfamide–gemcitabine in advanced non-small cell lung cancer carcinoma: two pilot studies;Berghmans;Anticancer Res,1999
4. Front-line treatment of advanced non-small cell lung cancer (NSCLC) with docetaxel (D) and gemcitabine (G): a multicenter phase II trial;Georgoulias;JCO,1999
5. Docetaxel and Gemcitabine administered on days 1 and 8 for metastatic non-small cell lung carcinoma (NSCLC): a phase II multicenter trial;Hirsh;Lung Cancer,2004